BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25344940)

  • 1. Glypican 3 expression in pediatric malignant solid tumors.
    Kinoshita Y; Tanaka S; Souzaki R; Miyoshi K; Kohashi K; Oda Y; Nakatsura T; Taguchi T
    Eur J Pediatr Surg; 2015 Feb; 25(1):138-44. PubMed ID: 25344940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases.
    Zynger DL; Gupta A; Luan C; Chou PM; Yang GY; Yang XJ
    Hum Pathol; 2008 Feb; 39(2):224-30. PubMed ID: 17949790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glypican 3 expression in hepatoblastoma and its diagnostic implication].
    Wang FH; Wen JM; Vong HT; Yip YC
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):806-9. PubMed ID: 24507097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glypican 3: a novel marker in testicular germ cell tumors.
    Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ
    Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE; Pate LL; Longacre TA
    Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
    Kinoshita Y; Tajiri T; Souzaki R; Tatsuta K; Higashi M; Izaki T; Takahashi Y; Taguchi T
    J Pediatr Hematol Oncol; 2008 Jun; 30(6):447-50. PubMed ID: 18525461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glypican 3 overexpression in primary and metastatic Wilms tumors.
    Tretiakova M; Zynger DL; Luan C; Andeen NK; Finn LS; Kocherginsky M; Teh BT; Yang XJ
    Virchows Arch; 2015 Jan; 466(1):67-76. PubMed ID: 25366870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
    Kandil DH; Cooper K
    Adv Anat Pathol; 2009 Mar; 16(2):125-9. PubMed ID: 19550373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of glypican-3 in pediatric tumors: an analysis of 414 cases.
    Chan ES; Pawel BR; Corao DA; Venneti S; Russo P; Santi M; Sullivan LM
    Pediatr Dev Pathol; 2013; 16(4):272-7. PubMed ID: 23530909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of glypican 3 in ovarian and extragonadal germ cell tumors.
    Zynger DL; Everton MJ; Dimov ND; Chou PM; Yang XJ
    Am J Clin Pathol; 2008 Aug; 130(2):224-30. PubMed ID: 18628091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of glypican-3 is highly associated with pediatric hepatoblastoma: a systemic analysis.
    Xiong XL; Qin H; Yan SQ; Zhou LS; Chen P; Zhao D
    Asian Pac J Cancer Prev; 2015; 16(3):1029-31. PubMed ID: 25735325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glypican-3 expression in Wilms tumor and hepatoblastoma.
    Toretsky JA; Zitomersky NL; Eskenazi AE; Voigt RW; Strauch ED; Sun CC; Huber R; Meltzer SJ; Schlessinger D
    J Pediatr Hematol Oncol; 2001 Nov; 23(8):496-9. PubMed ID: 11878776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.
    Zhou S; Parham DM; Yung E; Pattengale P; Wang L
    Histopathology; 2015 Dec; 67(6):905-13. PubMed ID: 25939253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors.
    Ortiz MV; Roberts SS; Glade Bender J; Shukla N; Wexler LH
    Front Oncol; 2019; 9():108. PubMed ID: 30873384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions.
    Kandil D; Leiman G; Allegretta M; Trotman W; Pantanowitz L; Goulart R; Evans M
    Cancer; 2007 Oct; 111(5):316-22. PubMed ID: 17763368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncofetal protein glypican-3 in testicular germ-cell tumor.
    Ota S; Hishinuma M; Yamauchi N; Goto A; Morikawa T; Fujimura T; Kitamura T; Kodama T; Aburatani H; Fukayama M
    Virchows Arch; 2006 Sep; 449(3):308-14. PubMed ID: 16896894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and diagnostic value of a novel oncofetal protein: glypican 3.
    Wang SK; Zynger DL; Hes O; Yang XJ
    Adv Anat Pathol; 2014 Nov; 21(6):450-60. PubMed ID: 25299314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma.
    Yamauchi N; Watanabe A; Hishinuma M; Ohashi K; Midorikawa Y; Morishita Y; Niki T; Shibahara J; Mori M; Makuuchi M; Hippo Y; Kodama T; Iwanari H; Aburatani H; Fukayama M
    Mod Pathol; 2005 Dec; 18(12):1591-8. PubMed ID: 15920546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of glypican 3 (GPC3) in embryonal tumors.
    Saikali Z; Sinnett D
    Int J Cancer; 2000 Sep; 89(5):418-22. PubMed ID: 11008203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.